Loyal

Loyal

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.loyal.com

Last Round

Series C

Feb 11, 2026

Est. Valuation

$425M

Total Funding Raised

$205M

Momentum Score

25 /100

Company Overview

Loyal is a veterinary pharmaceuticals company that creates medications aimed at enhancing the health span and lifespan of dogs by delaying the onset of age-related diseases such as cancer, heart conditions, and metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

canine longevity drugdog longevity druglifespan extension drugcanine healthspanveterinary pharmaceuticalsanti-aging for dogsveterinary biotechclinical-stage biotechcanine prescription drugscanine geroscienceFDA approval processsenior dog healthlarge-breed dog healthB2B2C pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Loyal Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Loyal Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 11, 2026
Series B ExtensionFeb 26, 2025
Series BMar 21, 2024
Series ASep 23, 2021
SeedJan 1, 2020

Key People

Founding team and executive leadership

Celine Halioua

Founder CEO

Founding Team

Loyal Investors

Notable investors and investment history

InvestorRounds
Bain Capital VenturesSeries B Extension, Series B
Khosla VenturesSeries B, Seed, Series B Extension, Series A
age1Series C
Todd & Rahul CapitalSeries B
Collaborative FundSeries B, Series A, Seed, Series B Extension
First Round CapitalSeries B, Series A, Seed, Series B Extension
BoxGroupSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    $100M round raised.

  • Jan 1, 2026

    Two of three review sections completed for lead program LOY-002.

Loyal Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Loyal Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Loyal's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range197
Year Founded2020
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.